PubAg

Main content area

VEGF is essential for the growth and migration of human hepatocellular carcinoma cells

Author:
Zhang, Lei, Wang, Jia-Ning, Tang, Jun-Ming, Kong, Xia, Yang, Jian-Ye, Zheng, Fei, Guo, Ling-Yun, Huang, Yong-Zhang, Zhang, Li, Tian, Lin, Cao, Shu-Fen, Tuo, Chang-Hai, Guo, Hong-Li, Chen, Shi-You
Source:
Molecular biology reports 2012 v.39 no.5 pp. 5085-5093
ISSN:
0301-4851
Subject:
Western blotting, adhesion, angiogenesis, carcinoma, chemotaxis, endothelial cells, hepatoma, humans, mitogenesis, permeability, protein kinase C, reverse transcriptase polymerase chain reaction, tissue repair, transcription factor NF-kappa B, vascular endothelial growth factor receptors, vascular endothelial growth factors
Abstract:
Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF induces new vessel formation and tumor growth by inducing mitogenesis and chemotaxis of normal endothelial cells and increasing vascular permeability. However, little is known about VEGF function in the proliferation, survival or migration of hepatocellular carcinoma cells (HCC). In the present study, we have found that VEGF receptors are expressed in HCC line BEL7402 and human HCC specimens. Importantly, VEGF receptor expression correlates with the development of the carcinoma. By using a comprehensive approaches including TUNEL assay, transwell and wound healing assays, migration and invasion assays, adhesion assay, western blot and quantitative RT-PCR, we have shown that knockdown of VEGF165 expression by shRNA inhibits the proliferation, migration, survival and adhesion ability of BEL7402. Knockdown of VEGF165 decreased the expression of NF-κB p65 and PKCα while increased the expression of p53 signaling molecules, suggesting that VEGF functions in HCC proliferation and migration are mediated by P65, PKCα and/or p53.
Agid:
1298988